Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-21-000359

Chief Financial Officer sold 10,000 shares at an average $507.22 ($5,072,165)

  • Chief Financial Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hippel James · Chief Financial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-02 Exercise or conversion : show line 1 in the form +10,000 $106.59 $1,065,900 20,855 D
2021-09-02 Sale : show line 2 in the form −9,993 $507.22 $5,068,600 10,862 D
2021-09-02 Sale : show line 3 in the form −7 $509.17 $3,564 10,855 D
Open-market sales · 10,000 sh · avg $507.22 · $5,072,165

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-09-02 Exercise or conversion : show line 4 in the form Stock Options (Right to Buy) −10,000 0 D
Loading xslF345X03/edgar.xml…